- Category Marryalyan
- DATE 23 Nov 2022
Melanoma and Skin Cancer Trials Limited (MASC Trials)
November 2022
Melanoma and Skin Cancer Trials Limited (MASC Trials) is Australia and New Zealand’s collaborative clinical trials group committed to improving melanoma and skin cancer outcomes.
Working with leading researchers, MASC Trials conducts multicentre, national and international clinical trials at more than 110 institutions in Australia and overseas. Our diverse and growing portfolio includes research in the prevention, early detection and treatment of melanoma and skin cancer, including early to late phase clinical trials.
As of late October 2022, we had enrolled 1004 new participants in 12 active trials (open and closed to recruitment) at 141 sites across 11 countries. These achievements are testament to the fantastic work of our investigators and their teams throughout the world.
Recent highlights include:
Launch of the BETTER trial, which will test a new treatment combination in patients with symptomatic melanoma brain metastases. The trial has been made possible thanks to a $100,000 donation from the Australian Skin Cancer Foundation. Currently in start-up phase, the BETTER trial will evaluate the safety, tolerability and efficacy of combining the immunotherapy drugs nivolumab and ipilimumab with bevacizumab and targeted radiotherapy in patients with melanoma brain metastases who have symptoms from their disease and are not suitable for surgical treatment.
Boosting the MelMarT-II trial’s international efforts recently was a collaborative agreement with the USA’s National Cancer Institute’s National Clinical Trials Network (NCI-NCTN) through the SWOG Cooperative Group. This development has allowed for an additional 90 USA sites to join the trial, which is investigating whether there is a difference in disease-free survival for patients treated with either a 1cm or 2cm excision margin for stage II primary cutaneous melanoma.
The IMAGE trial, which is examining the effectiveness of early detection 2D and 3D Melanoma Surveillance Photography, has now recruited over 500 participants. IMAGE trial participant, Mr Viv Chapman, said “Being in this trial has given me so much peace of mind because I’m not leaving things up to chance or hoping someone happens to notice a small change in one of the many marks on my body.” Read Viv’s story.
MASC Trials developed a patient and consumer centred education initiative funded by Cancer Australia to help melanoma and skin cancer patients aged 60+ living rural and regional Australia.
The outcomes of a consumer survey informed the development and delivery of evidence-based education resources. Working with Melanoma Patients Australia, the Self-Skin Checks, No Regrets education campaign was launched in early June 2022 and featured social media and media coverage, a website with a large range of evidence-based resources, self-skin check information, patient stories and more.
Events
2023 Annual Scientific Meeting
Date: Thursday, 23 March 2023
Time: 2:00pm - 5:00pm AEST
Venue: Brisbane Convention and Exhibition Centre
The ASM will be a satellite meeting of the Australasian Melanoma Conference (24-25 March 2023, Brisbane).
Register here: https://www.masc.org.au/asm-2023/
The MASC Trials ASM brings together experts in melanoma and skin cancer clinical trials and consumers, and will be attended by the many disciplines critical to our work. The program includes a stellar line-up of leaders in their fields who will discuss the latest clinical research in melanoma and skin cancer. Updates on MASC Trials’ research portfolio and opportunities for new research collaborations will form part of the meeting. Consumer presentations will also provide a unique perspective on our patient engagement.
3rd AOMA Summit
The Australasian Ocular Melanoma Alliance (AOMA) is a special interest group of MASC Trials. Held in July, the 3rd AOMA Virtual Summit was attended by consumers and those working in ocular melanoma from all over the world. View the scientific and consumer sessions: https://www.masc.org.au/aoma-2022/
Supporting clinical trials
High quality clinical trials require significant and sustained financial investment to deliver real-world results. To expand our critical work, we are looking beyond government funding and are developing our partnerships and fundraising activity. To help us improve the lives of melanoma and skin cancer patients in Australia and globally, please donate to MASC Trials at https://www.masc.org.au/donate/

Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow

COSAoncology 16 hours ago
We are pleased that @MOGA_ORG continue to be an Affiliated member organisation with COSA, and look forward to our ongoing collaboration to improve cancer care and control.MOGA provided their Marryalyan Report for COSA’s June eNews: bit.ly/4kpHz3V
Read More >
COSAoncology 4 days ago
Thank you again to @RANZCRcollege for continuing your COSA Affiliated membership. RANZCR members are reminded to take advantage of the Affiliated discount for COSA memberships: bit.ly/3s5mOC6
Read More >
COSAoncology 6 days ago
Thanks to @ESSA_NEWS for renewing as a COSA Associated organisation and continuing to collaborate with COSA. A reminder that ESSA members are invited to take advantage of discounted COSA membership: bit.ly/3s5mOC6
Read More >
COSAoncology 13 days ago
Our Nutrition Group is hosting a Speed Networking Event on Fri 25 July for COSA members to get to know leading dietitians and researchers including Jane Stewart, Merran Findlay & Emily Jeffery. Connect with COSA members interested in nutrition and cancer! bit.ly/4nmK8GU
Read More >
COSAoncology 14 days ago
The Tom Reeve Award recognises a national leader who's made significant contributions to cancer care. The award will be presented at COSA-IPOS 2025 in Adelaide in November where the recipient is invited to deliver an address. Nominations closing 14 July. bit.ly/3hIXWcV
Read More >
COSAoncology 18 days ago
Have you renewed your COSA membership yet? You might like to renew before 30 June 2025: bit.ly/4cI0nc3
Read More >
COSAoncology 20 days ago
Our June member newsletter is out now. Check your inbox for the latest COSA news and updates including new resources, events, opportunities and peer-reviewed journal articles. Or log in and view it online anytime at bit.ly/4kRIRpp
Read More >
COSAoncology 21 days ago
COSA is the national oncology community bringing together multidisciplinary health professionals across all cancers to advance care and improve outcomes. More on member benefits here: bit.ly/3BwXvwL
Read More >
COSAoncology 28 days ago
If you selected automatic renewal, expect to see an email from COSA today. Please check your details in the email, and update your billing in your COSA account if needed. bit.ly/4cI0nc3
Read More >
COSAoncology 28 days ago
Check out what your membership supported COSA to achieve in the last year! Renew your membership to continue collaborating with COSA: bit.ly/4cI0nc3
Read More >